Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells

Authors

  • Donna Crabtree,

    1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Search for more papers by this author
  • Matthew Dodson,

    1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    2. Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Search for more papers by this author
  • Xiaosen Ouyang,

    1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    2. Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    3. Department of Veterans Affairs, Birmingham VA Medical Center, Birmingham, Alabama, USA
    Search for more papers by this author
  • Michaël Boyer-Guittaut,

    1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    2. Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    3. Laboratoire de Biochimie, U.F.R. Sciences et Techniques, Université de Franche-Comté, Besançon Cedex, France
    Search for more papers by this author
  • Qiuli Liang,

    1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    2. Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    3. Department of Veterans Affairs, Birmingham VA Medical Center, Birmingham, Alabama, USA
    Search for more papers by this author
  • Mary E. Ballestas,

    1. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Search for more papers by this author
  • Naomi Fineberg,

    1. Department of Biostatistics, UAB School of Public Health, Birmingham, Alabama, USA
    Search for more papers by this author
  • Jianhua Zhang

    Corresponding author
    1. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    2. Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    3. Department of Veterans Affairs, Birmingham VA Medical Center, Birmingham, Alabama, USA
    • Address correspondence and reprint requests to Jianhua Zhang, Department of Pathology, University of Alabama at Birmingham, BMRII-534, 901 19th Street S, Birmingham, AL 35294, USA. E-mail: zhanja@uab.edu

    Search for more papers by this author

Abstract

Parkinson's disease is a neurodegenerative movement disorder. The histopathology of Parkinson's disease comprises proteinaceous inclusions known as Lewy bodies, which contains aggregated α-synuclein. Cathepsin D (CD) is a lysosomal protease previously demonstrated to cleave α-synuclein and decrease its toxicity in both cell lines and mouse brains in vivo. Here, we show that pharmacological inhibition of CD, or introduction of catalytically inactive mutant CD, resulted in decreased CD activity and increased cathepsin B activity, suggesting a possible compensatory response to inhibition of CD activity. However, this increased cathepsin B activity was not sufficient to maintain α-synuclein degradation, as evidenced by the accumulation of endogenous α-synuclein. Interestingly, the levels of LC3, LAMP1, and LAMP2, proteins involved in autophagy-lysosomal activities, as well as total lysosomal mass as assessed by LysoTracker flow cytometry, were unchanged. Neither autophagic flux nor proteasomal activities differs between cells over-expressing wild-type versus mutant CD. These observations point to a critical regulatory role for that endogenous CD activity in dopaminergic cells in α-synuclein homeostasis which cannot be compensated for by increased Cathepsin B. These data support the potential need to enhance CD function in order to attenuate α-synuclein accumulation as a therapeutic strategy against development of synucleinopathy.

image

Insufficiencies in the autophagy-lysosome pathway may contribute to neurodegenerative disease pathogenesis and progression. We found that a catalytically inactive mutant cathepsin D (D295N CD) decreases endogenous CD activity, similar to inhibition of endogenous CD activity by the addition of CD inhibitor, PepA, leads to accumulation of α-synuclein, without significant changes of overall autophagy activities. As accumulation of α-synuclein is a main pathological feature of Parkinson's disease (PD), this study further demonstrate a crucial role of CD activities in attenuation of synucleinopathies such as PD.

Ancillary